Concha A, Ruiz-Cabello F, Cabrera T, Nogales F, Collado A, Garrido F
Department of Pathological Anatomy, General Hospital of Baza, Granada, Spain.
Eur J Immunogenet. 1995 Aug;22(4):299-310. doi: 10.1111/j.1744-313x.1995.tb00246.x.
Fifteen samples of non-tumoural breast tissue, 24 cases of benign lesions, four biopsies of inflammatory carcinomas and 94 tumour samples of primitive mammary carcinomas were analysed for HLA class II expression. We found, first, that HLA class II antigens were detectable in all cases of non-neoplastic breast tissue. Secondly, HLA class II antigen expression was notably increased in benign neoplasms and hyperplastic lesions. In contrast, only 32 out of 94 carcinomas showed expression of HLA-DR antigens, 17 tumours had HLA-DP antigens and 11 carcinomas were positive for the presence of DQ molecules. The expression of class II antigen was associated with the degree of histological differentiation (P < 0.05) but was independent of stromal leucocytic infiltration. Thirdly, HLA-DR was very strongly expressed in intravascular tumoural thrombi, especially in the 'inflammatory carcinomas'. The immunophenotype of inflammatory infiltrate was analysed in benign and malignant lesions. In malignant lesions the mean number of inflammatory cells was significantly higher than in benign lesions. Interestingly, we found no differences in the amount and composition of inflammatory infiltrate between HLA-DR positive and negative tumours.
对15份非肿瘤性乳腺组织样本、24例良性病变、4份炎性癌活检样本以及94份原发性乳腺癌肿瘤样本进行了HLA II类表达分析。首先,我们发现,在所有非肿瘤性乳腺组织病例中均可检测到HLA II类抗原。其次,HLA II类抗原表达在良性肿瘤和增生性病变中显著增加。相比之下,94例癌中只有32例显示HLA-DR抗原表达,17例肿瘤有HLA-DP抗原,11例癌DQ分子呈阳性。II类抗原的表达与组织学分化程度相关(P<0.05),但与基质白细胞浸润无关。第三,HLA-DR在血管内肿瘤血栓中表达非常强烈,尤其是在“炎性癌”中。分析了良性和恶性病变中炎性浸润的免疫表型。在恶性病变中,炎性细胞的平均数量显著高于良性病变。有趣的是,我们发现HLA-DR阳性和阴性肿瘤之间炎性浸润的数量和组成没有差异。